Arthur M Friedlander is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of immunology, particularly in the development of vaccines against the plague. With a total of 4 patents to his name, Friedlander has demonstrated a commitment to advancing medical science.

Latest Patents

Friedlander's latest patents include innovative methods and compositions related to plague vaccines. One of his key patents is focused on treatment methods using an F1-V plague vaccine. This patent discloses a method of inducing an immunological response in a subject by administering an immunogenic amount of a purified fusion protein comprising all or part of the F1 antigen fused to the amino terminus of the V antigen. Another significant patent is for a recombinant F1-V plague vaccine, which describes a composition comprising a purified fusion protein that is isolated from its expression vector.

Career Highlights

Arthur M Friedlander works for the US Government as represented by the Secretary of the Army. His role in this esteemed organization highlights his dedication to public health and safety. His work has been instrumental in developing effective vaccines that can protect against serious infectious diseases.

Collaborations

Friedlander has collaborated with notable colleagues, including Susan L Welkos and George W Anderson, Jr. These partnerships have likely contributed to the success of his research and the advancement of vaccine technology.

Conclusion

Arthur M Friedlander is a distinguished inventor whose work in plague vaccine development has made a significant impact on public health. His innovative patents and collaborations reflect his dedication to advancing medical science and improving health outcomes.